Related Experiment Videos
[Coagulation factor VIII in the early postpartum period]
M Procházka1, J Procházková, M Lubuský
1Porodnicko-gynekologická klinika FN a LF UP, Olomouc.
Ceska Gynekologie
|May 28, 2005
Summary
Postpartum factor VIII:C levels significantly decrease after pregnancy, returning to non-pregnant ranges. While elevated factor VIII:C during pregnancy is common, persistent high levels post-delivery warrant thrombophilia screening.
Area of Science:
- Obstetrics and Gynecology
- Hematology
- Thrombosis Research
Context:
- Pregnancy significantly alters coagulation and fibrinolytic systems.
- Elevated coagulation factor VIII (VIII:C) is a known risk factor for thrombosis during pregnancy and the postpartum period.
Purpose:
- To investigate the changes in factor VIII:C levels during the early postpartum period.
- To assess the association between elevated factor VIII:C and pregnancy outcomes.
Summary:
- A prospective study of 197 healthy women found mean factor VIII:C levels of 194.09% in the early postpartum period, with 60.4% exceeding 150%.
- Post-puerperal testing in 59 women revealed a significant decrease in factor VIII:C to a mean of 139.76%, aligning with non-pregnant levels.
- Elevated factor VIII:C during pregnancy did not correlate with adverse pregnancy outcomes, though higher levels were associated with blood group A.
Impact:
- Provides crucial data on the normalization of factor VIII:C in the postpartum period.
- Highlights the importance of monitoring persistent high factor VIII:C levels for potential thrombophilia.
- Informs clinical practice regarding thrombotic risk assessment in postpartum women.